Discipline: Reumatologie

Reumatologie, therapie vandaag en de uitdagingen van morgen

Voor de meest frequent voorkomende reumatologische aandoeningen kunnen nieuwe therapieën de komende jaren wellicht weinig meerwaarde bieden ten opzichte van…

Reumatologen gaan de strijd aan met het volledige spectrum van reumatologische aandoeningen

Qua behandelingsopties onderging reumatologie als discipline een ware revolutie in de voorbije twee decennia. De heterogeniteit van reumatische aandoeningen laat…

Actuele behandelingen bij reumatoïde artritis

De afgelopen jaren zijn de behandelingsmogelijkheden bij reumatoïde artritis (RA) expansief toegenomen. We onderscheiden Disease Modifying Antirheumatic Drugs (DMARDs) en…

Publicaties

Poussée sévère d’une dermatomyosite pré-existante chez une patiente avec un adénocarcinome pulmonaire traité par pembrolizumab, un anti-PD-1 [Life-threatening flare of an underlying «paraneoplastic» dermatomyositis in a patient with lung adenocarcinoma treated with anti-PD-1 pembrolizuma].

01/07/2022

Gebruikersnaam
Wachtwoord

	Onthoud mij Wachtwoord vergeten?

Discipline: Reumatologie

Reumatologie, therapie vandaag en de uitdagingen van morgen

Reumatologen gaan de strijd aan met het volledige spectrum van reumatologische aandoeningen

Actuele behandelingen bij reumatoïde artritis

Publicaties

Myositis specific and associated autoantibodies (MSA-ab).

Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases.

Off-label use of mycophenolate mofetil in the treatment of rare and complex rheumatic connective tissue diseases.

Positioning of myositis-specific and associated autoantibody (MSA/MAA) testing in disease criteria and routine diagnostic work-up.

Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies.

Anti-RuvBL1/2 autoantibodies in patients with systemic sclerosis or idiopathic inflammatory myopathy and a nuclear speckled pattern.

Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study.

Idiopathische inflammatoire myopathieën (deel 1, 2 en 3).

Development of eosinophilic fasciitis during treatment with certolizumab pegol for ankylosing spondylitis.

Pitfalls in the detection of myositis specific antibodies by lineblot in clinically suspected idiopathic inflammatory myopathy.

Idiopathic inflammatory myopathies: narrative review of unmet needs in clinical practice guidelines.

Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.

RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients.

Correlative imaging in crowned dens syndrome.

Anakinra in resistant gout: a case report.

Assessment of sensitivity to change of the European Scleroderma Study Group activity index.

Disease activity indices in systemic sclerosis: a systematic literature review.

EULAR Study Group on Microcirculation in Rheumatic Diseases. Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis.

Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis.

Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study.

The heart and pulmonary arterial hypertension in systemic sclerosis.

IgG4-related disease: The utility of (18)F-FDG PET/CT in diagnosis and treatment.

Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis.

Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvement.

Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement?

Presentaties

Allogeneic stem cell transplantation in refractory rheuma toid arthritis: A case report.

KBVR Working group on rare connective tissue diseases: Where are we and where do we want to go?

Myositis specific and associated autoantibodies (MSA-ab).

Workshop on electromyography.

Systemic diseases.

Physicians’ reasons for prescribing Janus kinase inhibitors (JAKi) in patients with rheumatoidarthritis, and associated alignment between physicians and patients in a real-world clinical setting.

A rare case of adult-onset phalangeal microgeodic syndrome.

hysician and patient attitudes towards treat-to-target, its implementation and stated treatment goals in patients with rheumatoid arthritis in a real-world setting across Europe.

Prevalence of clinical symptoms and laboratory markers in idiopathic inflammatory myopathies.

The impact of temperature on the evaluation of myositis specific antibodies by lineblot.

Fast track algorithm: how to differentiate a scleroderma pattern from a non-scleroderma pattern.

Case report.

20th Belgian Congres on Rheumatology. Quiz.

Rare cases of bone fragility or disorders (case reports).

Assessment of Sensitivity to Change of the Disease Activity Score (DAS) in Systemic Sclerosis (SSc).

Four years follow-up of an open-label pilot study of treatment with rituximab in patients with early, diffuse cutaneous systemic sclerosis.

Two years follow-up results of a multicenter, open-label pilot study with rituximab in patients with early, diffuse cutaneous systemic sclerosis.

Stabilisation of microcirculation in patients with early systemic sclerosis with diffuse skin involvement treated with rituximab.

Synovial fluid derived invariant Natural Killer T cells in chronic arthritides show an increased Programmed Death-1 expression and anerghic phenotype.

Two years follow-up results of an open pilot study of fixed repeated treatment with rituximab in patients with “early” systemic sclerosis with diffuse skin involvement.